Welcome back, {First Name}

The Journey to Blüm: Crafting a New Kind of Pastille

Medically reviewed by
published
20 November 2024
The Journey to Blüm: Crafting a New Kind of Pastille
4 minute read
20 November 2024

How does an idea become a ground-breaking product? Until recently, patients seeking effective extended relief from pain, anxiety, or sleepless nights found themselves navigating a limited selection of cannabis edibles — or turning to unreliable and potentially unsafe homemade products for their healthcare needs.

Frustrated by this lack of choices for our patients, we recognised a significant gap and set course to make things right. Our mission was clear: to create high-quality pastilles (also known as edibles) that were not only accessible for Australian patients but ones that could rival the best pastille products available globally.

But how did we embark on this ambitious journey that ended up with four unique therapeutic formulations and 24 premium pastille squares in every Blüm tin? Let’s take a closer look at the milestones that paved our path to palatable, precise, and patient-friendly success.

The Timeline of Blüm

A Taste of Inspiration
April 2023
Blüm's journey began with a simple but powerful idea—to revolutionise the pastille treatments in Australia. Our founders, Chris and Grace, envisioned high-quality pastilles that could offer patients a better option for extended medicinal cannabis relief.

Building Partnerships for Innovative Pastilles
May 2023

Chris made a pivotal connection by reaching out to experienced medicinal cannabis edibles manufacturers in Canada—ideal partners for our mission. Their expertise and commitment to quality laid the groundwork for our collaboration. Shortly after, we took a significant step forward by importing samples for research and development. This initiative allowed us to critically assess existing market options and identify gaps we could fill with our own offerings.

The Art of Packaging Design
June - August 2023
With compliance secured, our attention turned to packaging design. This phase was not just about aesthetics; it was about creating an experience that reflected the quality of our pastilles. We worked closely with our suppliers to develop a custom outer tin and clamshell packaging that highlights our brand identity while prioritising safety.

Our packaging incorporates tamper-evident seals and child-resistant closures to prevent accidental access, ensuring the highest safety standards are maintained. Additionally, we are conducting stability studies on the tins to ensure their suitability for the Australian medical market.

Building the “Blüm” Brand
June - October 2023
During this time, our brand began to take shape. We brainstormed, collaborated, and refined our identity—Blüm. This wasn’t just a name; it represented our commitment to excellence and a brighter future for Australian patients.

Taste Meets Strategy: R&D for Logistics
September 2023
In September, we imported additional samples to refine our logistics and flavour profiles. Every detail mattered; we were on a mission to ensure our pastilles were not only precise but also palatable, making them a preferred choice for patients.

Formulating Excellence
October - December 2023
With a clear vision in place, the formulation work began. Our team delved into clinical ratios for symptom relief, flavour profiles, and sourcing high-quality ingredients. Each pastille would embody our commitment to patient well-being.

Collaborations Across Borders
January - March 2024
As we stepped into the new year, Chris and Grace travelled to Canada to meet with the formulation team and manufacturing partners This collaboration was pivotal, allowing us to solidify our partnerships. Chris established a key relationship with our GMP packaging partner for packaging solutions.

Turning Dreams into Reality: The First Sample Production Run
March - July 2024
A milestone moment arrived when we completed our first sample production run. The excitement was infectious as we realised we were transforming our vision into a reality. The journey was truly underway.

First Commercial Production Run Commenced
August 2024
In August, we proudly commenced our first production run, marking a significant step towards making Blüm available to patients.

Blüm Goes Live
October 2024
Finally, the moment we had all been waiting for arrived—Blüm went live! This launch signified not just the culmination of our hard work but a new chapter in offering accessible, high-quality pastilles to Australian patients.

Blüm’s journey from idea to reality has been all about creativity, teamwork, and a passionate focus on quality. From the start, our goal has been simple: to give Australian patients pastille that not only offer relief but are palatable too. We're excited to bring this vision to life with the hope that each pastille makes a real difference in people’s lives. Blüm isn’t just another product on the shelf; it’s our way of reshaping the pastille experience in Australia, one square at a time.

References